The Apple Watch Series 10 is the newest generation mainstream model (the Watch Series 11 isn't expected until September of this year). Improvements over the Apple Watch Series 9 include a bigger ...

Overall, Fisher Investments benefits from a strong investment culture, earning it an Above Average Parent Pillar rating. Portfolio management turnover has been minimal at the firm over the past ...

As a shopping writer, I use Camelcamelcamel, Honey, SlickDeals, and others to help me determine whether online deals are, well, the real deal. Figuring out the best time to buy something requires ...

Carrie Underwood and her husband, Mike Fisher, made a rare red carpet appearance together when they attended the star-studded “Opry 100: A Live Celebration” gala March 19 at the Grand Ole Opry ...

The couple attended the 'Opry 100' live special on March 19 Catherine Santino is a Style Writer-Reporter at PEOPLE. She began as a contributor for PEOPLE in 2022 and joined the staff full-time in ...

Following last month’s announcement, Google is now rolling out a redesign of Android’s Family Link app for parents. The goal is to bring the “most important tools and resources for managing ...

Following the web introduction on Tuesday, Gemini Canvas is now rolling out to the Android and iOS app with a redesign of the plus menu. Instead of a list, the ‘plus’ menu now places Camera ...

WhatsApp Web just received a visual update that's rolling out widely. The changes are subtle, but they mimic the app's UI on Android. UI changes are minor, but they make text easier to read and ...

The producer prices of industrial products were 0.7% higher in February 2025 than in February 2024. In January 2025, the year-on-year change rate was +0.5%. The Federal Statistical Office (Destatis) ...

As it continues to test a dramatic redesign of its app, Plex has announced several other imminent changes. In a blog post today, the company announced a price increase for its Plex Pass ...

The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year. Why: The stock's decline ...